热门出版物 - 学术资源搜索

h5 指数:86
h5 中位数:117

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#2 Hematology
#18 Oncology

标题/作者	引用次数	年份
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. A Hochhaus, G Saglio, TP Hughes, RA Larson, DW Kim, S Issaragrisil, ... Leukemia 30 (5), 1044-1054	417	2016
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo. D Sommermeyer, M Hudecek, PL Kosasih, T Gogishvili, DG Maloney, ... Leukemia 30 (2), 492-500	324	2016
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068	315	2015
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. P Baliakas, A Hadzidimitriou, LA Sutton, D Rossi, E Minga, N Villamor, ... Leukemia (08876924) 29 (2)	261	2015
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. JL Steegmann, M Baccarani, M Breccia, LF Casado, V García-Gutiérrez, ... Leukemia 30 (8), 1648-1671	233	2016
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia. SS Kenderian, M Ruella, O Shestova, M Klichinsky, V Aikawa, ... Leukemia (08876924) 29 (8)	223	2015
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, ... Leukemia 31 (10), 2094-2103	223	2017
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. NC Cross, HE White, D Colomer, H Ehrencrona, L Foroni, E Gottardi, ... Leukemia 29 (5), 999-1003	219	2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study. V Goede, K Fischer, A Engelke, R Schlag, S Lepretre, LF Montero, ... Leukemia 29 (7), 1602	215	2015
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. CN Harrison, AM Vannucchi, JJ Kiladjian, HK Al-Ali, H Gisslinger, ... Leukemia 30 (8), 1701-1707	212	2016
The concept of treatment-free remission in chronic myeloid leukemia. S Saußele, J Richter, A Hochhaus, FX Mahon Leukemia 30 (8), 1638-1647	190	2016
MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. K Musilova, M Mraz Leukemia (08876924) 29 (5)	188	2015
The MLL recombinome of acute leukemias in 2017. C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ... Leukemia 32 (2), 273-284	185	2018
Isocitrate dehydrogenase mutations in myeloid malignancies. BC Medeiros, AT Fathi, CD DiNardo, DA Pollyea, SM Chan, R Swords Leukemia 31 (2), 272-281	176	2017
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. DJ DeAngelo, KE Stevenson, SE Dahlberg, LB Silverman, S Couban, ... Leukemia (08876924) 29 (3)	169	2015
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms. D Pietra, E Rumi, VV Ferretti, CAB Di, C Milanesi, C Cavalloni, ... Leukemia 30 (2), 431-438	163	2016
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation. S Kamel, L Horton, L Ysebaert, M Levade, K Burbury, S Tan, ... Leukemia (08876924) 29 (4)	161	2015
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. NM Kröger, JH Deeg, E Olavarria, D Niederwieser, A Bacigalupo, ... Leukemia 29 (11), 2126-2133	157	2015
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV. L Kalmanti, S Saussele, M Lauseker, MC Müller, CT Dietz, L Heinrich, ... Leukemia (08876924) 29 (5)	154	2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group. J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ... Leukemia 30 (5), 1005-1017	147	2015

1 - 20

计算机程序会自动估算并确定日期和引用次数。